Page last updated: 2024-09-04

ezetimibe and Mucopolysaccharidosis IV

ezetimibe has been researched along with Mucopolysaccharidosis IV in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alméciga-Diaz, CJ; Garzón, R; Gorshkov, K; Guzman, E; Hidalgo, OA; Li, R; Olarte-Avellaneda, S; Pimentel-Vera, LN; Puentes-Tellez, MA; Rodríguez-López, A; Rojas-Rodriguez, AF; Zheng, W	1

Other Studies

1 other study(ies) available for ezetimibe and Mucopolysaccharidosis IV

Article	Year
Identification of Ezetimibe and Pranlukast as Pharmacological Chaperones for the Treatment of the Rare Disease Mucopolysaccharidosis Type IVA. Journal of medicinal chemistry, 2019, 07-11, Volume: 62, Issue:13 Topics: Catalytic Domain; Chondroitinsulfatases; Chromones; Enzyme Inhibitors; Ezetimibe; Fibroblasts; HEK293 Cells; Humans; Lysosomes; Microtubule-Associated Proteins; Molecular Docking Simulation; Molecular Dynamics Simulation; Mucopolysaccharidosis IV; Pichia; Protein Binding; Protein Stability; Rare Diseases; Recombinant Proteins; RNA-Binding Proteins	2019

Article

Year

Identification of Ezetimibe and Pranlukast as Pharmacological Chaperones for the Treatment of the Rare Disease Mucopolysaccharidosis Type IVA.

Journal of medicinal chemistry, 2019, 07-11, Volume: 62, Issue:13

Topics: Catalytic Domain; Chondroitinsulfatases; Chromones; Enzyme Inhibitors; Ezetimibe; Fibroblasts; HEK293 Cells; Humans; Lysosomes; Microtubule-Associated Proteins; Molecular Docking Simulation; Molecular Dynamics Simulation; Mucopolysaccharidosis IV; Pichia; Protein Binding; Protein Stability; Rare Diseases; Recombinant Proteins; RNA-Binding Proteins

2019